Help! It's DARA! 

Course Objectives:

1. Define what Daratumumab is and what it is used to treat.
2. Summarize the perspectives of how treated patients are handled in each facility.
3. State the steps to find compatible blood products for patients treated with Daratumumab.

Speakers:

• Sheri Hugan, MLS(ASCP) - SBBCM IRL Senior Clinical Technologist, Michigan Medicine
• Kathryn Watkins, MT (ASCP) - Clinical Pathology, Transfusion Medicine, Beaumont Health
• Brigitte Becker, MT (ASCP) SBB^CM - Sparrow Hospital - CLS in charge (Blood Bank), Scheurer Hospital - Medical Technologist
• Kayla Waider, MLS (ASCP)^CM - IRL Technologist III, American Red Cross Biomedical Services, Southeast Michigan Region

Registration Deadline: Friday, April 19